Anti-U1 RNP antibody is shared by various CTDs, presenting in 6–17% of SSc patients [35], 13–30% of SLE patients [36], 2–20% of pSS patients [30,37], and 100% of MCTD patients [21]. Here, U1 is linked to mixed connective tissue disease.